sparfloxacin has been researched along with phenylalanine arginine beta-naphthylamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chevalier, J; Davin-Regli, A; Dupont, M; Lavigne, JP; Pagès, JM; Sotto, A; Tran, QT | 1 |
| Alibert, S; Chevalier, J; Handzlik, J; Kieć-Kononowicz, K; Otrębska, E; Pagès, JM; Pękala, E; Szymańska, E | 1 |
2 other study(ies) available for sparfloxacin and phenylalanine arginine beta-naphthylamide
| Article | Year |
|---|---|
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
Topics: Bacterial Proteins; beta-Lactamases; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cefepime; Cephalosporinase; Cephalosporins; Drug Resistance, Bacterial; Enterobacter aerogenes; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2009 |
Search for new tools to combat Gram-negative resistant bacteria among amine derivatives of 5-arylidenehydantoin.
Topics: Amines; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Humans; Hydantoins; Models, Molecular | 2013 |